JP2023500116A5 - - Google Patents

Info

Publication number
JP2023500116A5
JP2023500116A5 JP2022525706A JP2022525706A JP2023500116A5 JP 2023500116 A5 JP2023500116 A5 JP 2023500116A5 JP 2022525706 A JP2022525706 A JP 2022525706A JP 2022525706 A JP2022525706 A JP 2022525706A JP 2023500116 A5 JP2023500116 A5 JP 2023500116A5
Authority
JP
Japan
Prior art keywords
trem
con
rare
trna
codon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022525706A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023500116A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/058948 external-priority patent/WO2021092064A1/en
Publication of JP2023500116A publication Critical patent/JP2023500116A/ja
Publication of JP2023500116A5 publication Critical patent/JP2023500116A5/ja
Pending legal-status Critical Current

Links

JP2022525706A 2019-11-04 2020-11-04 con-希少コドンのためのTREM組成物及び関連する使用 Pending JP2023500116A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962930361P 2019-11-04 2019-11-04
US62/930,361 2019-11-04
PCT/US2020/058948 WO2021092064A1 (en) 2019-11-04 2020-11-04 Trem compositions for con-rare codons and related uses

Publications (2)

Publication Number Publication Date
JP2023500116A JP2023500116A (ja) 2023-01-04
JP2023500116A5 true JP2023500116A5 (cg-RX-API-DMAC10.html) 2023-11-14

Family

ID=73654885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022525706A Pending JP2023500116A (ja) 2019-11-04 2020-11-04 con-希少コドンのためのTREM組成物及び関連する使用

Country Status (9)

Country Link
US (1) US20220364092A1 (cg-RX-API-DMAC10.html)
EP (1) EP4055163A1 (cg-RX-API-DMAC10.html)
JP (1) JP2023500116A (cg-RX-API-DMAC10.html)
KR (1) KR20220128611A (cg-RX-API-DMAC10.html)
CN (1) CN115003810A (cg-RX-API-DMAC10.html)
AU (1) AU2020379762A1 (cg-RX-API-DMAC10.html)
CA (1) CA3160097A1 (cg-RX-API-DMAC10.html)
MX (1) MX2022005362A (cg-RX-API-DMAC10.html)
WO (1) WO2021092064A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020004587A (es) 2017-11-02 2021-04-12 Univ Iowa Res Found Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt.
JP7712270B2 (ja) 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
EP4158032A2 (en) * 2020-05-29 2023-04-05 Flagship Pioneering Innovations VI, LLC Trem compositions and methods relating thereto

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801030A (en) 1995-09-01 1998-09-01 Genvec, Inc. Methods and vectors for site-specific recombination
US6693086B1 (en) 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
US20080318884A1 (en) * 2005-03-25 2008-12-25 The Uab Research Foundation Methods for Altering Gene Expression and Methods of Treatment Utilizing Same
GB0600948D0 (en) * 2006-01-18 2006-02-22 Univ Dundee Prevention/Treatment Of Ichthyosis Vulgaris, Atopy And Other Disorders
WO2010141851A1 (en) * 2009-06-05 2010-12-09 Salk Institute For Biological Studies Improving unnatural amino acid incorporation in eukaryotic cells
US9676810B2 (en) * 2010-07-08 2017-06-13 The Brigham And Women's Hospital, Inc. Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules
KR102485491B1 (ko) * 2012-10-02 2023-01-04 벡션 테라퓨틱스 엘엘씨 면역 조절성 미니세포 및 사용 방법
BR112016011195A2 (pt) 2013-11-18 2017-09-19 Rubius Therapeutics Inc Células eritroides enucleadas e seus métodos de fabricação, composição farmacêutica e seu uso, uso de uma população de células eritroides, biorreator, mistura de células e dispositivo médico
CN106456744A (zh) 2014-04-01 2017-02-22 鲁比厄斯治疗法股份有限公司 用于免疫调节的方法和组合物
WO2016183482A1 (en) 2015-05-13 2016-11-17 Rubius Therapeutics, Inc. Membrane-receiver complex therapeutics
CN108697733A (zh) 2016-01-11 2018-10-23 鲁比厄斯治疗法股份有限公司 与癌症适应症的多模式治疗性细胞体系有关的组合物和方法
MX2019000205A (es) 2016-07-07 2019-09-23 Rubius Therapeutics Inc Composiciones y metodos relacionados con sistemas celulares terapeuticos que expresan arn exogeno.
BR112019011138A2 (pt) 2016-12-02 2019-10-01 Rubius Therapeutics, Inc. composições e métodos relacionados com sistemas celulares para penetração em tumores sólidos
CN110520522A (zh) 2017-02-17 2019-11-29 鲁比厄斯治疗法股份有限公司 功能化红系细胞
US11576872B2 (en) 2017-05-08 2023-02-14 Flagship Pioneering Innovations V, Inc. Compositions for facilitating membrane fusion and uses thereof
EA202190736A1 (ru) * 2018-09-26 2021-09-16 Кейс Вестерн Ризерв Юниверсити Способы и композиции для увеличения экспрессии белка и/или лечения расстройства, связанного с гаплонедостаточностью
IL284878B2 (en) * 2019-01-18 2026-04-01 Flagship Pioneering Inc TREM preparations and their uses
JP2022534988A (ja) * 2019-05-31 2022-08-04 フラッグシップ パイオニアリング, インコーポレイテッド tRNAプールを調節するためのTREMの使用

Similar Documents

Publication Publication Date Title
Baik et al. Initial transcriptome and proteome analyses of low culture temperature‐induced expression in CHO cells producing erythropoietin
EP3191526B1 (en) Wnt signaling agonist molecules
Watanabe Unique features of animal mitochondrial translation systems–The non-universal genetic code, unusual features of the translational apparatus and their relevance to human mitochondrial diseases–
Haque et al. The effect of mutated mitochondrial ribosomal proteins S16 and S22 on the assembly of the small and large ribosomal subunits in human mitochondria
CA2182217A1 (en) Comparative gene transcript analysis
Komar A code within a code: how codons fine-tune protein folding in the cell
EP4071178A1 (en) Method for producing peptide having physiological activity, and peptide comprising short linker
KR20230020991A (ko) 최적화된 뉴클레오티드 서열의 생성
TW202246309A (zh) 用於靶向蛋白質降解的合成降解系統
Ding Generation of patient-specific motor neurons in modeling movement diseases
Hayduk et al. Cytochalasin D can improve heterologous protein productivity in adherent Chinese hamster ovary cells
Magistrati et al. Modopathies caused by mutations in genes encoding for mitochondrial RNA modifying enzymes: molecular mechanisms and yeast disease models
US10000548B2 (en) GAL-1 variants having immuno-modulating properties and methods of using the same
Ryu et al. Cyanobacteria join the kahalalide conversation: genome and metabolite evidence for structurally related peptides
JP2009500021A (ja) サイトカインのil−12ファミリーのポリヌクレオチドおよびポリペプチド
CN115697373A (zh) 线粒体衍生肽和其类似物作为包括癌症的年龄相关性疾病的治疗的用途
US20260092258A1 (en) Method to Rejuvenate Human Cells Through Transcriptional Reprogramming
JP2018191603A (ja) 遺伝性腎疾患アルポート症候群治療薬に係る評価系
JP2021048805A (ja) がんにおける融合遺伝子
CN116693626A (zh) 订书肽及其用途和在体外扩增干细胞的方法
Hutson et al. Abstract 1531 Mass spectrometry-based proteomic analysis of glioblastoma-derived extracellular vesicles and healthy brain cells for biomarkers identification
Arp et al. Multi-omic analysis reveals nitric oxide dependent remodeling in classically activated macrophages and identifies negative regulation mediated by AKR1A1
CN119708138B (zh) 一种仿刺参胶原蛋白肽及其应用
US20260038688A1 (en) Methods and systems of plasma cell-free rna as non-invasive biomarkers for parkinson's disease
Hävermark et al. Dynamic ribosome binding by trigger factor in vivo